The passage of a tracer, contrast agent, or physiological signal through tissue creates a changing signal over time. An analysis method interprets that time course to estimate distinct features, including blood volume, flow, transit time, or tissue enhancement. These measures describe complementary aspects of microcirculatory delivery rather than a single, interchangeable indicator of tissue perfusion.
Each provides a measurable marker of how blood moves through the microcirculation. The analysis tracks the marker as it reaches and leaves tissue, then relates its changing signal to perfusion parameters. Depending on the study, this marker may be an introduced tracer or contrast agent, or a naturally occurring physiological signal used to characterize tissue enhancement and delivery.
Structural imaging may show the shape or appearance of an organ without directly indicating whether its tissue receives sufficient blood supply. Perfusion measurements add functional information by identifying altered flow, blood volume, transit time, or enhancement. This distinction is clinically important because ischemia or impaired vascular function may be detectable through circulation changes before obvious anatomical abnormalities appear.
A typical workflow begins by selecting a measurable tracer, contrast agent, or physiological signal and acquiring observations as it passes through tissue. The resulting time-dependent data are then analyzed to quantify parameters such as flow, blood volume, transit time, or enhancement. Interpretation links those measurements to the condition of the examined organ or tissue.
In medicine, these methods can be applied to cerebral, cardiac, and renal tissue, as well as tumors. They help assess whether circulation is adequate and can reveal ischemia or impaired vascular function. In oncology-related evaluation, perfusion measurements may also show treatment-related changes, adding functional evidence to the assessment of tissue response.
Standardized analysis makes measurements more consistent when clinicians compare tissues, examinations, or changes over time. Consistent quantification of flow, blood volume, transit time, or enhancement can support diagnosis, treatment planning, and monitoring of disease progression. It also helps identify treatment-related changes that may not be apparent from anatomical assessment alone.